Implementing Prescriber-Pharmacist Collaborative Care for Evidence-based Anticoagulant Use
| Condition | Pulmonary Embolism, Venous Thromboembolism, Atrial Fibrillation |
|---|---|
| Phase | N/A |
| Sponsor | University of Michigan |
| Status | Completed |
| Enrollment | 306 participants |
| Interventions | New-prescription Alert, New-prescription Alert with referral option, Existing-prescription notification to prescriber, Existing-prescription notification to pharmacist |
| Start date | Aug 1, 2022 |
| Completion date | Dec 15, 2024 |
| Results posted | Mar 30, 2026 |
Summary
The researchers hypothesize that existing-prescription notifications directed to pharmacists are more likely to lead to a prescription change than existing-prescription notifications directed to prescribers. Furthermore, the researchers hypothesize that the availability of a pharmacist referral option is associated with a higher rate of prescription changes for initial-prescription alerts that are directed to the prescriber at the time of initial-prescribing errors. Findings from this project will establish a framework for implementing prescriber-pharmacist collaboration for high risk medications, including anticoagulants
The Number (Proportion) of Notifications (in the Existing-prescription Notification Conditions) That Are Addressed Within 7 Days.
| Notification Sent to Prescriber | 24.86 percent of notifications |
|---|---|
| Notification Sent to Pharmacist | 21.74 percent of notifications |
Open in BENITIONS View on ClinicalTrials.gov
Other trials for this condition
- Comparison of PolarX and the Arctic Front Cryoballoons for PVI in Patients With Symptomati — Insel Gruppe AG, University Hospital Bern
- Improving How Older Adults at Risk for Cardiovascular Outcomes Are Selected for Care Coord — Weill Medical College of Cornell University
- Amplatzer Amulet China Post Market Study (PMS) — Abbott Medical Devices
- Diagnostic Accuracy of WEARable TECHnology Single-lead ECG in Detecting Cardiac Arrhythmia — Oxford University Hospitals NHS Trust
- Rivaroxaban vs. Warfarin for Post Cardiac Surgery Atrial Fibrillation — Massachusetts General Hospital
- Impact of Anticoagulation Therapy on the Cognitive Decline and Dementia in Patients With N — Intermountain Health Care, Inc.